Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van der Meer

Showing results (11-20 of 418) with videos related to

Pageof 42
Sort By:
Nature Reviews. Cardiology|June 29, 2011
Acute coronary syndromes: the unfulfilled promise of erythropoietin in patients with MIPeter van der Meer, Dirk J van Veldhuisen
Heart (British Cardiac Society)|October 16, 2009
Anaemia and renal dysfunction in chronic heart failurePeter van der Meer, Dirk J van Veldhuisen
European Heart Journal|March 9, 2011
To bind or not to bind: potassium-lowering drugs in heart failurePeter van der Meer, Dirk J van Veldhuisen
European Journal of Heart Failure|March 26, 2011
Heart failure highlights in 2010Kevin Damman, Alexander H Maass, Peter van der Meer
European Heart Journal|November 10, 2025
Cardio-oncology across European Society of Cardiology member countries: a survey of the European Society of Cardiology Council of Cardio-OncologyDimitrios Farmakis, Peter van der Meer, Teresa Lopez-Fernandez
European Journal of Preventive Cardiology|February 24, 2021
Iron deficiency in heart failure-time to redefinePieter Martens, Niels Grote Beverborg, Peter van der Meer
Stem Cells Translational Medicine|October 11, 2018
Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue EngineeringMartijn F Hoes, Nils Bomer, Peter van der Meer
European Journal of Heart Failure|August 21, 2013
Haemodilution is a mechanism of anaemia in patients with heart failure: replyB Daan Westenbrink, Lennaert Kleijn, Peter van der Meer
Expert Opinion on Investigational Drugs|May 14, 2013
The potential role of valsartan + AHU377 ( LCZ696 ) in the treatment of heart failureAdriaan A Voors, Bernard Dorhout, Peter van der Meer
European Journal of Heart Failure|April 6, 2013
Erythropoietin and heart failure: the end of a promise?Lennaert Kleijn, B Daan Westenbrink, Peter van der Meer
Pageof 42

Showing results (11-20 of 418) with videos related to

Sort By:
Pageof 42
Nature Reviews. Cardiology|June 29, 2011
Acute coronary syndromes: the unfulfilled promise of erythropoietin in patients with MIPeter van der Meer, Dirk J van Veldhuisen
Heart (British Cardiac Society)|October 16, 2009
Anaemia and renal dysfunction in chronic heart failurePeter van der Meer, Dirk J van Veldhuisen
European Heart Journal|March 9, 2011
To bind or not to bind: potassium-lowering drugs in heart failurePeter van der Meer, Dirk J van Veldhuisen
European Journal of Heart Failure|March 26, 2011
Heart failure highlights in 2010Kevin Damman, Alexander H Maass, Peter van der Meer
European Heart Journal|November 10, 2025
Cardio-oncology across European Society of Cardiology member countries: a survey of the European Society of Cardiology Council of Cardio-OncologyDimitrios Farmakis, Peter van der Meer, Teresa Lopez-Fernandez
European Journal of Preventive Cardiology|February 24, 2021
Iron deficiency in heart failure-time to redefinePieter Martens, Niels Grote Beverborg, Peter van der Meer
Stem Cells Translational Medicine|October 11, 2018
Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue EngineeringMartijn F Hoes, Nils Bomer, Peter van der Meer
European Journal of Heart Failure|August 21, 2013
Haemodilution is a mechanism of anaemia in patients with heart failure: replyB Daan Westenbrink, Lennaert Kleijn, Peter van der Meer
Expert Opinion on Investigational Drugs|May 14, 2013
The potential role of valsartan + AHU377 ( LCZ696 ) in the treatment of heart failureAdriaan A Voors, Bernard Dorhout, Peter van der Meer
European Journal of Heart Failure|April 6, 2013
Erythropoietin and heart failure: the end of a promise?Lennaert Kleijn, B Daan Westenbrink, Peter van der Meer
Pageof 42